Recordati S.p.A

127 articles about Recordati S.p.A

• Recordati S.p.A In-Licenses Cardicor(R) in Italy From Merck KGaA

  12/27/2010

• Recordati In-Licenses Cardicor(R) in Italy From Merck KGaA

  12/27/2010

• Recordati S.p.A Pays Nymox Pharmaceutical EUR 10M ($13 M) Up Front for Rights to Late-Stage PBH Drug in 81 Countries; Nymox Shares up 59% as of 1:34PM EST

  12/17/2010

• Recordati S.p.A: Positive First Nine Months 2010 Results, EBIT and Net Income Increase

  10/26/2010

• Recordati S.p.A: Positive First Half 2010 Results, Ebit And Net Income Increase

  7/28/2010

• Recordati S.p.A: Positive Conclusion to the Decentralized Procedure for the Approval in Europe of Pitavastatin (Livazo(R))

  7/15/2010

• Recordati S.p.A Enters the Romanian Market Through the Acquisition of ArtMed

  6/8/2010

• Recordati S.p.A Signs An Agreement With Zambon For The Co-Marketing Of Silodosin In France

  5/7/2010

• Recordati S.p.A: Positive First Quarter 2010 Results, Sales And Income Increase. Three Year Business Plan Updated

  5/6/2010

• Recordati S.p.A To Meet With The Financial Community And Specialized Press In Milan

  4/27/2010

• Recordati S.p.A Shareholders Approve The 2009 Accounts. Dividend Eur 0.275 Per Share (+10.0%)

  4/13/2010

• Recordati S.p.A Signs Co-Marketing Agreement With Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) In Spain For Pitavastatin

  4/7/2010

• Recordati S.p.A's Carbaglu(R) Approved by the FDA for Use in the USA

  3/19/2010

• Recordati S.p.A And Lee's Pharmaceutical Announce Partnership For Zanidip(R) In China

  3/15/2010

• Recordati S.p.A: Preliminary Full Year 2009 Results In Line With Targets: Revenues +8.4%, Net Income +10.1%

  2/11/2010

• Recordati S.p.A: Silodosin (Urorec(R)/Silodyx) Approved By The European Commission For The Treatment Of The Signs And Symptoms Of Bph (Benign Prostatic Hyperplasia)

  2/3/2010

• U.S. Panel Urges Approval of Recordati S.p.A Blood Drug

  1/14/2010

• U.S. FDA Staff Question Study on Recordati S.p.A Blood Drug

  1/12/2010

• Recordati S.p.A: European Medicines Evaluation Agency Adopts A Positive Opinion For Silodosin (Brands Urorec(R) And Silodyx(R))

  11/20/2009

• Recordati S.p.A Signs An Agreement With Nycomed For The Co-Marketing Of Silodosin In Italy

  7/29/2009